Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
The RNA binding protein MUSASHI-2 (MSI2) is a potential therapeutic target for acute myeloid leukemia. Here the authors identify a small molecule inhibitor of MSI2 and characterize its effects in a murine leukemia model.
Main Authors: | Gerard Minuesa, Steven K. Albanese, Wei Xie, Yaniv Kazansky, Daniel Worroll, Arthur Chow, Alexandra Schurer, Sun-Mi Park, Christina Z. Rotsides, James Taggart, Andrea Rizzi, Levi N. Naden, Timothy Chou, Saroj Gourkanti, Daniel Cappel, Maria C. Passarelli, Lauren Fairchild, Carolina Adura, J. Fraser Glickman, Jessica Schulman, Christopher Famulare, Minal Patel, Joseph K. Eibl, Gregory M. Ross, Shibani Bhattacharya, Derek S. Tan, Christina S. Leslie, Thijs Beuming, Dinshaw J. Patel, Yehuda Goldgur, John D. Chodera, Michael G. Kharas |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2019-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10523-3 |
Similar Items
-
Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
by: Urmi Sengupta, et al.
Published: (2018-10-01) -
Miyamoto Musashi
by: Pablo Pereda González
Published: (2012-07-01) -
Miyamoto Musashi
by: Pablo Pereda González
Published: (2012-07-01) -
Miyamoto Musashi
by: Pablo Pereda González
Published: (2012-07-01) -
RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction
by: Mauro Montalbano, et al.
Published: (2020-08-01)